Sanofi Consumer Healthcare India Limited has informed the Exchange about change in designation of Ms. Nupur Gurbaxani, Director, Brand & Innovation as Senior Management Personnel of the Company.
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has designated Ms. Nupur Gurbaxani (Director, Brand & Innovation) and Mr. Viral Shah (Director, External Manufacturing) as Senior Management Personnel (SMP) with effect from 25th February 2026. Both are existing internal employees who have been with the company since 2024, with Nupur having over 18 years of experience from Godrej Consumer Products, Novartis, and Abbott Nutrition, and Viral bringing 20+ years of experience from Torrent, Ranbaxy, Merck, and Bayer. The change was approved by the Board on the recommendation of the Nomination & Remuneration Committee. This is a formal designation change under SEBI Listing Regulations, not a new hire or resignation.
This is a routine regulatory disclosure formalizing the SMP status of two existing senior leaders. No material impact on shareholders or stock price is expected, as the individuals were already serving in director-level roles at the company.